THE IMPACT OF P-GLYCOPROTEIN ON THE DISPOSITION OF DRUGS TARGETED FOR INDICATIONS OF THE CENTRAL NERVOUS SYSTEM: EVALUATION USING THE MDR1A/1B KNOCKOUT MOUSE MODEL

Knockout mouse Active metabolite P-glycoprotein Ratón
DOI: 10.1124/dmd.104.001230 Publication Date: 2004-10-23T00:24:47Z
ABSTRACT
Thirty-two structurally diverse drugs used for the treatment of various conditions central nervous system (CNS), along with two active metabolites, and eight non-CNS were measured in brain, plasma, cerebrospinal fluid P-glycoprotein (P-gp) knockout mouse model after subcutaneous administration, data compared corresponding obtained wild-type mice. Total brain-to-plasma (B/P) ratios CNS agents ranged from 0.060 to 24. Of 34 CNS-active agents, only 7 demonstrated B/P area under plasma concentration curve between P-gp mice that did not differ significantly unity. Most remaining 1.1- 2.6-fold greater versus Three, risperidone, its metabolite 9-hydroxyrisperidone, metoclopramide, showed marked differences (6.6- 17-fold). Differences fluid/plasma animals correlated. Through use this model, it appears most demonstrate at least some P-gp-mediated transport can affect brain concentrations. However, impact majority is probably minor. The example risperidone illustrates even good substrates still be clinically useful agents. such unbound concentrations may need than values projected using receptor affinity achieve adequate occupancy effect.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (31)
CITATIONS (383)